Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Schizophrenia, clinical and basic research at NIMH: A 75 Year retrospective.

Psychiatry research·2024
Same author

The Underuse of Clozapine and Long-Acting Injectable Antipsychotics.

Psychiatric services (Washington, D.C.)·2024
Same author

Monitoring redox stress in human airway epithelial cells exposed to woodsmoke at an air-liquid interface.

Particle and fibre toxicology·2024
Same author

Did the human genome project affect research on Schizophrenia?

Psychiatry research·2024
Same author

Mercury and Parkinson's Disease: Promising Leads, but Research Is Needed.

Parkinson's disease·2023
Same author

Case clusters of Parkinson's disease.

Clinical parkinsonism & related disorders·2023
Same journal

Communicating With Intubated Patients: Challenges Faced by Health Care Providers, Patients, and Family Members.

The primary care companion for CNS disorders·2026
Same journal

Fluoxetine-Induced Liver Injury in a Patient With Post-Schizophrenic Depression.

The primary care companion for CNS disorders·2026
Same journal

Beyond Pharmacology: Do Tablet Shape, Size, and Color Influence Medication Adherence in Psychiatric Outpatients?

The primary care companion for CNS disorders·2026
Same journal

Daily Fantasy Sports as an Emerging Public Health Concern: A Comparative Public Health Perspective of Digital Wagering and Youth Vulnerability.

The primary care companion for CNS disorders·2026
Same journal

Psychological Adverse Effects of Psychedelic Use.

The primary care companion for CNS disorders·2026
Same journal

Medical Complications of Psychedelics.

The primary care companion for CNS disorders·2026
See all related articles

Related Experiment Video

Updated: Jul 19, 2025

Subtype-selective Electroporation of Cortical Interneurons
06:42

Subtype-selective Electroporation of Cortical Interneurons

Published on: August 18, 2014

8.9K

The NIMH Research Portfolio: An Update.

E Fuller Torrey1,2,3, Wendy W Simmons1, Lisa Dailey2

  • 1Stanley Medical Research Institute, Rockville, Maryland.

The Primary Care Companion for CNS Disorders
|August 7, 2023
PubMed
Summary
This summary is machine-generated.

The National Institute of Mental Health (NIMH) increased its budget but decreased funding for clinical trials for severe mental illnesses. This shift prioritizes basic research over developing treatments for conditions like schizophrenia and bipolar disorder.

More Related Videos

A Mouse Model of Fatigue Induced by Peripheral Irradiation
04:15

A Mouse Model of Fatigue Induced by Peripheral Irradiation

Published on: March 17, 2017

7.9K
Acute Myocardial Infarction in Rats
07:45

Acute Myocardial Infarction in Rats

Published on: February 16, 2011

53.3K

Related Experiment Videos

Last Updated: Jul 19, 2025

Subtype-selective Electroporation of Cortical Interneurons
06:42

Subtype-selective Electroporation of Cortical Interneurons

Published on: August 18, 2014

8.9K
A Mouse Model of Fatigue Induced by Peripheral Irradiation
04:15

A Mouse Model of Fatigue Induced by Peripheral Irradiation

Published on: March 17, 2017

7.9K
Acute Myocardial Infarction in Rats
07:45

Acute Myocardial Infarction in Rats

Published on: February 16, 2011

53.3K

Area of Science:

  • Mental Health Research Funding
  • Psychiatric Disorder Research

Background:

  • The National Institute of Mental Health (NIMH) is a key funder of mental health research.
  • Assessing funding allocation is crucial for understanding research progress.

Purpose of the Study:

  • To evaluate NIMH's funding priorities since 2016.
  • To determine if basic research is prioritized over clinical research.

Main Methods:

  • Analysis of ClinicalTrials.gov and NIH Research, Condition, and Disease Categorization (RCDC) databases.
  • Assessment of NIMH funding for six psychiatric disorders (schizophrenia, bipolar disorder, depression, anxiety, eating disorders, autism) from 2016 onwards.

Main Results:

  • NIMH funding for schizophrenia and bipolar disorder research decreased by 22% and 20% respectively (2016-2021).
  • Clinical trial funding for schizophrenia and bipolar disorder was minimal (1 trial each, 2017-2022).
  • NIMH's budget increased by 40% during the same period, with a continued emphasis on basic research.

Conclusions:

  • NIMH's funding priorities favor basic research over clinical trials.
  • This trend may hinder the development of treatments for severe psychiatric disorders.